par de Azambuja, Evandro ;Piccart-Gebhart, Martine ;Procter, Marion;Agbor-Tarh, Dominique;Cameron, David A;Smith, Ian;Dowsett, Mitch;Van Veldhuisen, Dirk Jan;Metzger-Filho, Otto;Gelber, Richard;Steinseifer, Jutta;Suter, Thomas;Untch, Michael;Jackisch, Christian;Gianni, Luca;Baselga, José;Bell, Richard;Leyland-Jones, Brian
Référence Journal of clinical oncology, 32, 20, page (2159-2165)
Publication Publié, 2014-07
Référence Journal of clinical oncology, 32, 20, page (2159-2165)
Publication Publié, 2014-07
Article révisé par les pairs
Titre: |
|
Auteur: | de Azambuja, Evandro; Piccart-Gebhart, Martine; Procter, Marion; Agbor-Tarh, Dominique; Cameron, David A; Smith, Ian; Dowsett, Mitch; Van Veldhuisen, Dirk Jan; Metzger-Filho, Otto; Gelber, Richard; Steinseifer, Jutta; Suter, Thomas; Untch, Michael; Jackisch, Christian; Gianni, Luca; Baselga, José; Bell, Richard; Leyland-Jones, Brian |
Informations sur la publication: | Journal of clinical oncology, 32, 20, page (2159-2165) |
Statut de publication: | Publié, 2014-07 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Aged | |
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects | |
Antineoplastic Agents -- administration & dosage -- adverse effects | |
Breast Neoplasms -- chemistry -- drug therapy -- pathology -- surgery | |
Chemotherapy, Adjuvant | |
Drug Administration Schedule | |
Female | |
Follow-Up Studies | |
Heart Failure -- chemically induced | |
Humans | |
Incidence | |
Logistic Models | |
Mastectomy, Segmental | |
Middle Aged | |
Neoplasm Staging | |
Radiotherapy, Adjuvant | |
Receptor, ErbB-2 -- analysis | |
Tumor Markers, Biological -- analysis | |
Ventricular Function, Left -- drug effects | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2013.53.9288 | |
info:pii/JCO.2013.53.9288 | |
info:scp/84905858933 | |
info:pmid/24912899 |